| Ytd | 132.20% | |
| 1y | -16.41% |
| Open | 1.08 | Prev Close | 1.07 | Low | 1.08 | High | 1.11 | Mkt Cap | 6.52M |
| Vol | 127.00 | Avg Vol | 146.25K | EPS | -3.33 | P/E | -0.32 | Forward P/E | -0.59 |
| Beta | 1.03 | Short Ratio | 6.97 | Inst. Own | 17.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.21 | 200-d Avg | 0.96 | 1yr Est | 7.00 |
Gainers Lucid Group (NASDAQ:LCID) stock moved upwards by 19.1% to $5.5 during Wednesday's regul
XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a provider of wellness and bi
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), a
XWELL (NASDAQ: XWEL - Get Free Report) and HealthEquity (NASDAQ: HQY - Get Free Report) are both med
XWELL (NASDAQ: XWEL - Get Free Report) and Organon and Co. (NYSE: OGN - Get Free Report) are both sm
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"),
XWELL, Inc. (NASDAQ: XWEL - Get Free Report) was the recipient of a large decrease in short interest
XWELL (NASDAQ: XWEL - Get Free Report) and iSpecimen (NASDAQ: ISPC - Get Free Report) are both small
XWELL (NASDAQ: XWEL - Get Free Report) and Avantor (NYSE: AVTR - Get Free Report) are both medical c
XWELL, Inc. (NASDAQ: XWEL - Get Free Report) was the recipient of a large growth in short interest d
XWELL Inc (NASDAQ: XWEL) shares are surging on Wednesday following the company's announcement of a p
XWELL shares surged 158% after hours to $0.98 following a $31.3 million private placement announceme
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- XWELL Inc. (Nasdaq: XWEL), a provider of wellness and bi
Company Builds on U.S Biosecurity Leadership to Advance Pathogen Surveillance Internationally Compan
XWELL (NASDAQ: XWEL - Get Free Report) and Establishment Labs (NASDAQ: ESTA - Get Free Report) are b
NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- XWELL (Nasdaq: XWEL) (“XWELL” or the “Company”), a leadi
XWELL, Inc. (NASDAQ: XWEL - Get Free Report)'s stock price was down 3.5% during trading on Monday. T
NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- XWELL (Nasdaq: XWEL) (“XWELL” or the “Company”), a leade
Priority Pass members can now enjoy XWELL's exclusive wellness experiences at select international a